BioAura LabsResearch Vials
RESEARCH VIALS BIOAURA LABS
CJC with DAC
A DAC-modified analogue for comparative peptide research.
CJC with DAC is listed as a 5 mg research vial. DAC-modified CJC analogues are investigated for the relationship between peptide modification, protein interaction, and signaling behavior.
For laboratory research use only.
Not for human or veterinary use.
5 mg · Vials
SELECT YOUR PRESENTATION Catalog preview
TECHNICAL OVERVIEW
A DAC-modified analogue for comparative peptide research.
The DAC designation refers to a drug-affinity-complex modification in the CJC research family. It is a chemical distinction, not simply a different amount of a no-DAC material.
An accurate comparison requires the supplier’s exact peptide identity, modification, and analytical specification. BioAura’s catalog name is retained as supplied; a no-DAC sequence, formula, or molecular weight should not be substituted for the DAC-modified entry.
RESEARCH CONTEXT
Protein-interaction and stability research
Comparison with separately identified no-DAC materials
Specifications
- Catalog identity
- CJC with DAC
- Research classification
- Modified peptide · GHRH-analogue family
- Available presentations
- 5 mg · Vials
- Intended use
- For laboratory research use only. Not for human or veterinary use. Not for consumption or administration.
- Quantity interpretation
- Listed amounts identify catalog presentations, not doses. Confirm the content basis in the supplier specification.
- Identity and formulation
- Product identity, physical form, composition, analytical results, and supplier handling specifications must be matched to the BioAura lot.
- Lot-specific analytical results
- Pending. No purity, potency, sterility, endotoxin, or third-party testing claim is verified for this preview.
- Storage and stability
- Pending supplier instructions. No storage temperature, shelf life, or opened-container period is assigned.
Documentation & material status
Lot-specific records have not been supplied for this preview. Product imagery and general research literature do not establish the properties of a BioAura lot.
SPECTechnical specificationPending supplier verification
Product identity, physical form, composition, analytical results, and supplier handling specifications must be matched to the BioAura lot.
COACertificate of analysisLot-matched COA pending
Review the matching lot identifier, analytical methods, acceptance criteria, measured results, units, and issuing laboratory. A purity percentage alone does not establish content, identity, or suitability.
SDSSafety & handling recordsSupplier documentation pending
Obtain the relevant safety data, handling precautions, storage conditions, stability information, and disposal requirements before laboratory work.
PRODUCT QUESTIONS
Frequently Asked Questions
Can the no-DAC specifications be used for this listing?
No. The DAC modification changes the material identity. This entry requires its own supplier specification and lot analysis.
What does the listed presentation tell me?
5 mg · Vials. These are supplied catalog details. They do not specify an experimental concentration, dose, preparation procedure, or administration instruction.
Is this intended for human or veterinary use?
For laboratory research use only. Not for human or veterinary use. Not for consumption or administration. This page provides no treatment, dosing, reconstitution, or administration guidance.
Can I purchase through this preview?
No. Prices and shopping-bag interactions demonstrate the proposed store experience. Final prices, availability, shipping, and payment processing have not been activated.
CONTINUE EXPLORING